B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Signaling by EGFRvIII in Cancer

REACTOME PATHWAY
Reactome: R-HSA-56378125 genes40 compounds

The Signaling by EGFRvIII in Cancer pathway (Reactome ID: R-HSA-5637812) involves 5 genes and is affected by 40 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CDC37EGFRGRB2HSP90AA1PIK3R1

Compounds Affecting Signaling by EGFRvIII in Cancer

#CompoundTargets HitStudies
119-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]300
2celastrol300
3Quercetin300
4ag49014
5Wortmannin300
6triolimus [Supplementary Concept]33
7monorden8
8gedunin54
9Novobiocin300
10caffeic acid300
11Masoprocol300
12Tetracycline300
13Zearalenone (S-(E))-3,4,5,6,8,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradec in-1,7(8H)-dione.300
14myricetin-3-O-galactopyranoside [Supplementary Concept]300
152-Chloroadenosine 2-Chloroadenosine.300
16Adenylyl Imidodiphosphate 5'-Adenylic acid, monoanhydride with imidodiphosphoric acid.300
17Calcimycin216
18Calcitriol300
19Ciclopirox88
20Clotrimazole296
21cycloheximide300
22deguelin [Supplementary Concept]151
23Disulfiram297
24Hexachlorophene300
25Idarubicin299
26Indazoles300
27Miconazole298
28piceatannol300
29Nitroprusside299
30specioside6
31pictilisib25
32ly29400211
33alpelisib227
34Sirolimus300
35torin 110
36Dasatinib299
37Afatinib297
38tyrphostin ag 14784
39tyrphostin 11
40Dactinomycin297

About the Signaling by EGFRvIII in Cancer Pathway

The Signaling by EGFRvIII in Cancer pathway is catalogued in Reactome (ID: R-HSA-5637812) and involves 5 genes. In the BiohacksAI corpus, 40 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CDC37, EGFR, GRB2, HSP90AA1, PIK3R1.